ZyVersa Therapeutics Inc. (ZVSA)

1.10

-0.03 (-2.65%)

At close: Mar 03, 2025, 11:25 AM

ZyVersa Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20
Net Income	-98.3M	-14.05M	-8.08M	-12.68M
Depreciation & Amortization	10.4K	9.87K	10.4K	10.4K
Stock-Based Compensation	1.19M	3.52M	4.14M	3.83M
Other Working Capital	194.51K	1.67M	-708.45K	3.71M
Other Non-Cash Items	95.25M	1.47M	317.83K	288.37K
Deferred Income Tax	-9.48M	-745.05K	-441.58K	333.66K
Change in Working Capital	2.6M	8.29M	-1.02M	3.11M
Operating Cash Flow	-8.72M	-1.49M	-5.08M	-5.11M
Capital Expenditures	-1	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	1.69M
Common Stock Repurchased	-10.7M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	-12.15M	1.96M	5.23M	-126.4K
Financial Cash Flow	5.96M	1.87K	5.23M	4.56M
Net Cash Flow	-2.76M	370.74K	153.91K	-549.76K
Free Cash Flow	-8.72M	-1.49M	-5.08M	-5.11M